Use of pressor agents in shock in myocardial infarction.
D002318:Cardiovascular Diseases; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications*; D009638:Norepinephrine / Q000627:therapeutic use*; D012769:Shock / Q000209:etiology*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents
D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D009638:Norepinephrine
ARTERENOL/therapeutic use; MYOCARDIAL INFARCT/complications; SHOCK/etiology and pathogenesis; SYMPATHOMIMETICS/therapeutic use
J Pharm Pharmacol. 1952 Aug;4(8):560-5
12991207
Circulation. 1953 Apr;7(4):511-22
13033078
J Am Med Assoc. 1953 Apr 4;151(14):1163-5
13034451
Circulation. 1953 Dec;8(6):883-92
13106909
Circulation. 1954 Apr;9(4):527-32
13150516
Lancet. 1955 Jul 23;269(6882):151-4
13243673
Br Med J. 1955 Nov 19;2(4950):1250-2
13269844
Br Med J. 1955 Apr 16;1(4919):937-9
14363753
J Clin Invest. 1952 Feb;31(2):131-40
14907892
Am Heart J. 1952 Sep;44(3):407-27
14952464